Phio Pharmaceuticals (PHIO) Other Working Capital Changes (2011 - 2026)

Phio Pharmaceuticals (PHIO) has reported Other Working Capital Changes for 16 consecutive years, with $931000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes rose 157.89% year-over-year to $931000.0; the trailing twelve-month figure through Jun 2026 stood at $783000.0 (up 1103.85% YoY), and the FY2025 full-year result was $91000.0, up 118.92% from the prior year.
• Other Working Capital Changes rose to $931000.0 in Q2 2026 per PHIO's latest filing, from -$74000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $931000.0 in Q2 2026 and bottomed at -$778000.0 in Q3 2022.
• Historically, Other Working Capital Changes has averaged $29888.9 across 5 years, with a median of -$56500.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes sank 207.69% in 2024, then surged 318.7% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$345000.0 in 2022, then surged by 88.7% to -$39000.0 in 2023, then tumbled by 207.69% to -$120000.0 in 2024, then sank by 185.83% to -$343000.0 in 2025, then jumped by 371.43% to $931000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $931000.0, -$74000.0, and -$343000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.